X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2018 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare SUVEN LIFE with SHASUN PHARMA - Equitymaster
  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

SUVEN LIFE vs SHASUN PHARMA - Comparison Results

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    SUVEN LIFE SHASUN PHARMA SUVEN LIFE/
SHASUN PHARMA
 
P/E (TTM) x 19.3 123.9 15.6% View Chart
P/BV x 3.6 8.5 42.0% View Chart
Dividend Yield % 1.0 0.2 448.8%  

Financials

 SUVEN LIFE   SHASUN PHARMA
EQUITY SHARE DATA
    SUVEN LIFE
Mar-16
SHASUN PHARMA
Mar-14
SUVEN LIFE/
SHASUN PHARMA
5-Yr Chart
Click to enlarge
High Rs33994 359.3%   
Low Rs14446 316.7%   
Sales per share (Unadj.) Rs39.2214.2 18.3%  
Earnings per share (Unadj.) Rs7.55.3 139.8%  
Cash flow per share (Unadj.) Rs8.815.8 55.5%  
Dividends per share (Unadj.) Rs2.001.00 200.0%  
Dividend yield (eoy) %0.81.4 57.9%  
Book value per share (Unadj.) Rs49.053.3 91.9%  
Shares outstanding (eoy) m127.2856.62 224.8%   
Bonus/Rights/Conversions ---  
Price / Sales ratio x6.20.3 1,885.1%   
Avg P/E ratio x32.413.1 247.0%  
P/CF ratio (eoy) x27.54.4 622.7%  
Price / Book Value ratio x4.91.3 376.0%  
Dividend payout %26.818.7 143.0%   
Avg Mkt Cap Rs m30,7323,958 776.5%   
No. of employees `0001.0NA-   
Total wages/salary Rs m4162,164 19.2%   
Avg. sales/employee Rs Th5,236.1NM-  
Avg. wages/employee Rs Th436.5NM-  
Avg. net profit/employee Rs Th995.5NM-  
INCOME DATA
Net Sales Rs m4,99512,127 41.2%  
Other income Rs m194229 84.4%   
Total revenues Rs m5,18912,356 42.0%   
Gross profit Rs m1,2331,009 122.2%  
Depreciation Rs m167594 28.2%   
Interest Rs m54415 13.1%   
Profit before tax Rs m1,205230 524.5%   
Minority Interest Rs m00-   
Prior Period Items Rs m00 0.0%   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m255-73 -350.7%   
Profit after tax Rs m950302 314.3%  
Gross profit margin %24.78.3 296.6%  
Effective tax rate %21.2-31.7 -66.9%   
Net profit margin %19.02.5 763.1%  
BALANCE SHEET DATA
Current assets Rs m4,9866,884 72.4%   
Current liabilities Rs m1,0428,456 12.3%   
Net working cap to sales %79.0-13.0 -609.2%  
Current ratio x4.80.8 587.6%  
Inventory Days Days6162 99.0%  
Debtors Days Days39108 36.4%  
Net fixed assets Rs m3,1264,970 62.9%   
Share capital Rs m127113 112.4%   
"Free" reserves Rs m3,7172,875 129.3%   
Net worth Rs m6,2363,020 206.5%   
Long term debt Rs m4321,817 23.8%   
Total assets Rs m8,07913,347 60.5%  
Interest coverage x23.21.6 1,495.3%   
Debt to equity ratio x0.10.6 11.5%  
Sales to assets ratio x0.60.9 68.0%   
Return on assets %12.45.4 231.2%  
Return on equity %15.210.0 152.2%  
Return on capital %18.913.3 141.7%  
Exports to sales %87.546.4 188.7%   
Imports to sales %12.214.2 85.8%   
Exports (fob) Rs m4,3715,622 77.7%   
Imports (cif) Rs m6111,728 35.4%   
Fx inflow Rs m4,6665,843 79.9%   
Fx outflow Rs m9422,173 43.4%   
Net fx Rs m3,7243,669 101.5%   
CASH FLOW
From Operations Rs m922398 231.9%  
From Investments Rs m-619-1,635 37.9%  
From Financial Activity Rs m-6981,309 -53.4%  
Net Cashflow Rs m-39671 -555.8%  

Share Holding

Indian Promoters % 63.4 39.2 161.7%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 0.0 3.6 -  
FIIs % 0.0 17.6 -  
ADR/GDR % 0.0 0.0 -  
Free float % 36.5 39.6 92.2%  
Shareholders   37,287 20,750 179.7%  
Pledged promoter(s) holding % 0.0 12.3 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare SUVEN LIFE With:   PFIZER  GSK PHARMA  AUROBINDO PHARMA  DISHMAN PHARMA  GLENMARK PHARMA  

Compare SUVEN LIFE With:   ADCOCK INGRAM (S. Africa)  MYLAN (US)  ACTAVIS (US)  TEVA PHARMA (Israel)  



Today's Market

Indian Indices Continue to Fall, IT Sector Growth Projections, and Top Stocks in Action(Pre-Open)

On Wednesday, share markets in India opened in green but ended on a weak note. The BSE Sensex closed lower by 71 points to end the day at 33,704.

Related Views on News

Suven Lifesciences: Profits Decline due to Higher tax outgo in the quarter (Quarterly Results Update - Detailed)

Sep 22, 2017

Muted growth in CRAMS segment continues to impact topline.

Aster DM Healthcare (IPO)

Feb 10, 2018

Should you subscribe to the IPO of Aster DM Healthcare Ltd?

Dr Reddy's: Milestone Payment Drives Sales (Quarterly Results Update - Detailed)

Feb 9, 2018

US business was hit by pricing pressure although there was growth sequentially led by new product launches.

Lupin: US market Declines Due to Higher Base Effect of FY17 (Quarterly Results Update - Detailed)

Feb 9, 2018

Price erosion in generic US drugs continues but seems to be bottoming out.

Biocon: US Pricing Pressure Takes Toll (Quarterly Results Update - Detailed)

Feb 2, 2018

Pricing pressure in the US and costs of the Malaysian facility hit Biocon's profits in the third quarter.

More Views on News

Most Popular

Follow India's Super Investors to Make Big Money in the Market Crash(The 5 Minute Wrapup)

Feb 8, 2018

Has the sell-off in the markets left India's super investors unduly worried?

The Era of Easy Money is Coming to an End. What Happens Now?(Vivek Kaul's Diary)

Feb 9, 2018

The easy money policy of the Federal Reserve of the United States, which drove up stock markets all over the world, is ending, with the Federal Reserve looking to shrink its balance sheet.

The Markets Want Your Money. Don't Give It to Them.(Smart Contrarian)

Feb 9, 2018

MFs are having a gala time taking money from over-eager investors and funneling it into equities. Smart investors, though, know better than to do that.

The Big Gamble(The Honest Truth)

Feb 15, 2018

Once you accept the fact that elections are round the corner and that this budget is geared to reach a 40% target, everything makes sense.

Rising Dominance of Mutual Funds(Chart Of The Day)

Feb 8, 2018

Domestic money flow into Indian equities surpassed foreign fund flows in the recent years. But will it continue in volatile market?

More

Small Investments
BIG Returns

Zero To Millions Guide 2018
Get our special report, Zero To Millions
(2018 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

SUVEN LIFE SHARE PRICE


Feb 20, 2018 (Close)

TRACK SUVEN LIFE

  • Track your investment in SUVEN LIFE with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

SUVEN LIFE - PFIZER COMPARISON

COMPARE SUVEN LIFE WITH

MARKET STATS